Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8513887 | Journal of Pharmaceutical Sciences | 2017 | 30 Pages |
Abstract
Bile formation is a key function of the liver. Disturbance of bile flow may lead to liver disease and is called cholestasis. Cholestasis may be inherited, for example, in progressive familial intrahepatic cholestasis or acquired, for example, by drug-mediated inhibition of bile salt export from hepatocytes into the canaliculi. The key transport system for exporting bile salts into the canaliculi is the bile salt export pump. Inhibition of the bile salt export pump by drugs is a well-established cause of drug-induced cholestasis. Investigation of the role of the multidrug resistance protein 3, essential for biliary phospholipid secretion, is emerging now. This overview summarizes current concepts and methods with an emphasis on in vitro model systems for the investigation of drug-induced cholestasis in the general context of drug-induced liver injury.
Keywords
MDROATPMRPBSEPNtcpPFICFXRfarnesoid X receptorDrug-induced liver injuryhepatic transportOstDrug interactionsBile acid transportersTransportersABC transportersDILIorganic solute transportermultidrug resistance-associated proteinmultidrug resistance proteinOrganic anion transporting polypeptideBile salt export pumpProgressive familial intrahepatic cholestasis
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Bruno Stieger, Zainab M. Mahdi,